Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Deloitte
Accenture
Citi
Teva
Queensland Health
US Army
McKesson
Medtronic

Generated: April 24, 2018

DrugPatentWatch Database Preview

NYSTATIN Drug Profile

« Back to Dashboard

Which patents cover Nystatin, and what generic alternatives are available?

Nystatin is a drug marketed by Actavis Mid Atlantic, Crown Labs Inc, Fougera Pharms, G And W Labs Inc, Perrigo New York, Taro, Vintage, Paddock Llc, Gavis Pharms, Lyne, Mayne Pharma Inc, Nesher Pharms, Upsher-smith Labs, X Gen Pharms, Allied Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, Hi Tech Pharma, Morton Grove, Pharm Assoc, Pharmaderm, Pharmafair, Taro Pharm, Teva, Vintage Pharms, Vistapharm, Wockhardt Bio Ag, Heritage Pharms Inc, Quantum Pharmics, Sandoz, Sun Pharm Industries, Usl Pharma, Watson Labs, Fougera, Odyssey Pharms, Amneal Pharms Llc, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Perrigo Uk Finco, Akorn, Riconpharma Llc, Strides Pharma, and Teligent Pharma Inc. and is included in seventy-five NDAs.

The generic ingredient in NYSTATIN is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Drug patent expirations by year for NYSTATIN
Pharmacology for NYSTATIN
Ingredient-typePolyenes
Drug ClassPolyene Antifungal

US Patents and Regulatory Information for NYSTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 063305-001 Mar 29, 1993 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva NYSTATIN nystatin TABLET;ORAL 062506-001 Jan 16, 1984 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva NYSTATIN nystatin SUSPENSION;ORAL 062670-001 Jun 18, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva NYSTATIN nystatin TABLET;VAGINAL 062502-001 Dec 23, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Argus Health
Healthtrust
Baxter
Federal Trade Commission
US Army
Chubb
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.